NCT00052039

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: InterMune · Industry
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

Study GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b in patients wtih IPF. The study will be conducted primarily in Europe and will enroll 210 patients.

Conditions

• Lung Disease
• Pulmonary Fibrosis

Interventions

Type	Name	Description
DRUG	interferon-gamma 1b	This study was terminated prior to enrollment.
DRUG	azathioprine	This study was terminated prior to enrollment.

Timeline

• Start date: 2002-04-01
• Completion: 2002-06-01
• First posted: 2003-01-22
• Last updated: 2007-11-06

Locations

1 site across 1 country: Italy